CTLA4 and myalgic encephalomeyelitis/chronic fatigue syndrome: Considering the reversible nature of immune exhaustion highlighted above, the discovery of an immune checkpoint blockade such as CTLA-4, which revolutionized cancer therapy, underscores the potential of targeting exhaustion in patients with ME/CFS [125].